Navigation Links
Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
Date:4/21/2008

t may be repurposed or reformulated as potentially more effective or convenient treatments for their currently approved indications. Bennu's initial clinical programs include the treatment of aldehyde dehydrogenase ("ALDH2") deficiency and nephropathic cystinosis.

For additional information, please visit http://www.raptorpharma.com.

FORWARD LOOKING STATEMENTS

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future results of operation or future financial performance, including, but not limited to the following statements: the Company's ability to successfully develop Convivia(TM) or any of its other drug product candidates or technologies; the ability of Convivia(TM) to reduce peak systemic acetaldehyde levels in ALDH2 deficient persons following alcohol consumption; and the Company's ability to continue and conclude the Phase IIa study of the liquid injectible dose form of 4-MP. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our actual results to be materially different from these forward-looking statements. Factors which may significantly change or prevent our forward looking statements from fruition include that we may be unsuccessful in developing any products or acquiring products; that our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; that we are unable to retain or attract key employees whose knowledge is essential to the development of our products; that unforeseen scientific difficulties develop with our process; that our patents are not sufficient to protect essential aspects of our technology; that competitors may invent better technology; that our products may not work as well as hoped or worse, that ou
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Provides Update of Product Programs
2. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
5. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
6. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
7. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
8. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
9. Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R)
10. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
11. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... board of directors of Eli Lilly and Company (NYSE: ... the first quarter of 2010 of $0.49 a share ... is payable March 10, 2010 to shareholders of record ... 12, 2010. ,, Lilly, a leading innovation-driven corporation, is ... the latest research from its own worldwide laboratories and ...
(Date:12/14/2009)... Dec. 14 Zargis Medical Corp., a ... ) and a spin-off from Siemens Corporate Research ... it has begun selling its award-winning Zargis Cardioscan(TM) ... Cardioscan and its accompanying Bluetooth®-enabled electronic stethoscope were ... "2009 Innovation of the Year." Cardioscan ...
(Date:12/14/2009)... Gibraltar Associates, a leading public ... domestic communications and issues management, today announced ... PositiveID Corporation (Nasdaq: PSID ) to ... of record. Gibraltar Associates will conduct media ... the Company on its public relations programs. ...
Breaking Medicine Technology:Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation 2Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 1Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 2Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 3Bionovo Adds Dr Debu Tripathy to Their Medical Advisory Board 59431 1Bionovo Adds Dr Debu Tripathy to Their Medical Advisory Board 59431 2Bionovo Adds Dr Debu Tripathy to Their Medical Advisory Board 59431 3Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 1Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 2Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 3
(Date:12/14/2009)... could be linked to scans performed in 2007 , , ... are exposing patients to far more radiation than previously thought ... cancers a year, two new studies claim. , Based on ... Archives of Internal Medicine , the study authors, joined ... calling on clinicians to limit radiation exposure to patients. , ...
(Date:12/14/2009)... Type 2 diabetes and obesity are linked to an ... suggested that insulin glargine (a synthetic insulin preparation marketed ... a higher risk of certain cancers than other insulins ... were unable to control for important factors such as ... On the other hand, a large randomized trial designed ...
(Date:12/14/2009)... for meth and smoking, but concerns about prescription ... -- Fewer teenagers are using methamphetamine, but reductions ... prescription drugs remains high, U.S. health officials report. ... such as the hallucinogenic salvia leaf and the ... of attention-deficit hyperactivity disorder (ADHD), appear to be ...
(Date:12/14/2009)... Health Workforce Recommendations are Implemented ,, ... must ensure that health reform includes a ... to ensure implementation of an integrated, coordinated ... Steven A Wartman, president and CEO of ... "With each step in the legislative ...
(Date:12/14/2009)... is a statement of Matthew L. Myers, President, ... ) ,, The 2009 Monitoring the Future Survey ... Abuse shows that the nation continues to make ... have slowed significantly compared to the dramatic gains ... news, the survey also finds that smokeless tobacco ...
Breaking Medicine News(10 mins):Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:Health Reform Needs Enforceable National Workforce Strategy 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 3Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 4Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 5
... Society of Cardiology (ESC) is calling for concerted action ... the World Heart Organisation (WHO). // ... full extent of the global burden of chronic diseases ... is anticipated that a global action to prevent chronic ...
... upon the foods we eat, the products we buy, the ... we spend time // . Evaluation of stimulus valence is ... uses it as a basic category for organizing information and ... to be immediate, unintentional and linked to behavioral responses. ...
... agreement in principle to enable the smooth transfer of ... is an encouraging sign for Indian bioscience. But slow ... India’s grandiose scheme to become the global hub of ... of becoming a major player. , ,Discussions in ...
... alarming rise in human cases of bird flu, causing increasing ... strong resolve in the scientific community to combat this impending ... flu has risen since October 5 when scientists from the ... reported finding similarities between the bird flu strain in Asia, ...
... dream come true for the scientists who been working hard ... expected to take an extra step ahead as it is ... as well as their offspring, are safe to eat., ... techniques, with Canadian Scientists having proved themselves following the success ...
... against, a London based leading drug company, GlaxoSmithKline for ... to the U.S. Food and Drug Administration two years ... review. This became evident last November when The FDA ... , ,The Public Citizen Group has registered a ...
Other Medicine News:Health News:Conditioning preferences in children 2Health News:Biologicals Transfer Proposal between US and Indian Biotechnology 2Health News:FDA Mislead On Asthma Drug By GlaxoSmithKline 2
... the new PRONEB® ULTRA compressor. This high ... while delivering more medication to the patient's ... PLUS® or PARI LC STAR® Reusable Nebulizer, ... for inhalation and retention into the lungs. ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
... TREK™ Compact Compressor is for active patients ... anywhere and everywhere. The compressor is small ... source optionsworldwide AC compatibility (100 to 240V), ... patients the freedom to take aerosol treatments ...
... ,Allied Healthcares Timeter® PCS 414 portable air compressor ... that you may wonder if its running. Youll ... a durable, mar-resistant steel case thats easy to ... 26.5 pounds. The PCS 414 has been engineered ...
Medicine Products: